Correlation Between Intra-abdominal Pressure, Biomarkers of Bacterial Translocation and Intestinal Wall Damage : Study of the Relationship Between Intra-abdominal Pressure, Biomarkers of Bacterial Translocation and Intestinal Wall Damage in Multiple Organ Dysfunction Syndrome.
The aim of the project is to evaluate the impact of intra-abdominal hypertension, biomarkers of bacterial translocation and biomarkers of intestinal wall damage on the course and outcomes of the disease in patients with multiple organ dysfunction.Today the intestinal microflora translocation is considered as one of the key mechanism of an enhanced systemic inflammatory response that leads to multiple organ dysfunction. In the intensive care unit, in patients in serious condition changes in various body systems develop, including the immune system reacts with the production of endogenous pro-inflammatory mediators, and due to microcirculation disorders, ischemia and hypoxia of the intestinal wall, aggravated by an increase in intra-abdominal pressure, its permeability increases, its barrier function is impaired. As a result, bacteria and/or their endotoxins penetrate the damaged intestinal barrier and further enhance the immune response, which becomes systemic and ultimately leads to multiple organ dysfunction. When the described processes occur, the assessment of splanchnic blood flow becomes especially relevant.sCD14-ST (presepsin) and LBP (lipopolysaccharide-binding protein) are being studied as biomarkers of bacterial translocation, and I-FABP (Intestinal fatty-acid binding protein), REG3α (regenerating islet-derived protein-3α) and Zonulin (zonulin) are being studied as biomarkers of intestinal wall injury.The interaction of the macrophage membrane protein CD14 with peptidoglycans of gram-positive and lipopolysaccharides of the walls of gram-negative bacteria leads to the production of sCD14-ST. Presepsin is a biomarker for the early phase of sepsis and a predictor of outcome in septic patients.LBP increases the sensitization of receptors of cells of the immune system: macrophages, monocytes, neutrophils to bacterial lipopolysaccharide, which leads to the activation of the immune response by releasing pro-inflammatory mediators. LBP appears to be an effective biomarker for bacterial translocation and the development of septic complications.I-FABP is a protein that is located on the villi of mature enterocytes. An increase in the level of I-FABP in the blood serum is associated with a violation of the permeability of the intestinal wall, which has been proven in a number of studies.Paneth cells secrete the antimicrobial protein REG3α into the intestine, and in case of the intestinal wall damage, it moves into the bloodstream. This protein is a reliable biomarker of intestinal wall damage.Zonulin is a protein that playing a significant role in intestinal wall permeability. It opens the intracellular tight junctions between the cells of the duodenum and small intestine, which leads to an increase in the permeability of the intestinal wall. Therefore, serum zonulin is a marker of dysfunction and increased permeability of the intestinal barrier.In the databases of publications (Scopus, Web of Science) there were no articles on the study of the relationship between the level of biomarkers of intestinal translocation, the level of biomarkers of the intestinal wall damage and the level of intra-abdominal pressure in patients with multiple organ dysfunction syndrome. This study will allow a more in-depth study of the pathogenesis of intestinal microflora translocation in patients with multiple organ dysfunction syndrome, and will also allow using the results obtained to predict the course of this condition.Detection of blood serum biomarkers sCD14-ST, LBP, I-FABP, REG3α and Zonulin will be performed by enzyme immunoassay. The level of intra-abdominal pressure will be measured by the method of tonometry in the bladder through a urethral catheter using a portable invasive low pressure meter (IIND - 500/75) by Triton-Electronics LLC.The expected scientific results of studying the relationship between intra-abdominal pressure, the phenomenon of translocation of intestinal microflora into the systemic circulation with the pathogenesis and dynamics of the development of multiple organ dysfunction syndrome will have an impact on the further improvement of the treatment tactics of this pathology. Innovative methods for diagnosing the phenomenon of intestinal microflora translocation will have a positive effect on the development of laboratory diagnostics and science in Kazakhstan.Revealing of relationships between intestinal microflora translocation biomarkers, biomarkers of the intestinal wall damage and changes in intra-abdominal pressure will allow a more in-depth study of the pathogenetic mechanisms in the development and course of the multiple organ dysfunction syndrome, depending on its genesis, which will allow using the results obtained to predict the outcomes of this syndrome.2.2. The aim of the project is to evaluate the impact of intra-abdominal hypertension, biomarkers of bacterial translocation, and biomarkers of the intestinal wall damage on the course and outcomes of the disease in patients with multiple organ dysfunction.2.3. Project objectives:To evaluate the indicators of biomarkers of translocation of the intestinal microflora and biomarkers of the intestinal wall damage in the systemic circulation during the development and course of the syndrome of multiple organ dysfunction. Based on the obtained critical levels of markers of translocation of the intestinal microflora and markers of the intestinal wall damage, it will be possible to predict adverse outcomes in patients with multiple organ dysfunction syndrome.To identify differences in the level of markers of bacterial translocation of the intestinal microflora and the level of markers of the intestinal wall damage in patients with intra-abdominal hypertension. In patients with multiple organ dysfunction syndrome, the levels of biomarkers of bacterial translocation of the intestinal microflora and biomarkers of intestinal wall damage in the blood serum correlate with intra-abdominal pressure indicators, regardless of the etiology of intra-abdominal hypertension.Assess the impact of the level of intra-abdominal pressure on the development and course of the syndrome of multiple organ dysfunction. To assess the course of the syndrome of multiple organ dysfunction, an additional prognostic marker is the determination of the critical level of intra-abdominal pressure.Determine the critical levels of biomarkers of intestinal microflora translocation and biomarkers of intestinal wall damage to predict the outcome of diseases accompanied by the development of multiple organ dysfunction syndrome. The obtained critical levels of biomarkers of translocation of the intestinal microflora and biomarkers of the intestinal wall damage will be significant indicators in the syndrome of multiple organ dysfunction for predicting an unfavorable outcome.3. Scientific novelty and significance of the project Multiple Organ Dysfunction Syndrome (MODS) is a potentially reversible physiological disorder involving two or more organ systems not involved in the process resulting in intensive care unit (ICU) hospitalization. MODS results in longer ICU stays and, in severe cases, leads to high mortality (27%-100%).In this scientific project, it is planned to study the levels of biomarkers of bacterial translocation (sCD14-ST, LBP) levels of biomarkers of intestinal wall damage (I-FABP, REG3α and Zonulin) and intra-abdominal pressure in patients with multiple organ dysfunction syndrome.The interaction of the macrophage membrane protein CD14 with peptidoglycans of gram-positive and lipopolysaccharides of the walls of gram-negative bacteria leads to the production of sCD14-ST . Presepsin is a biomarker for the early phase of sepsis and a predictor of outcome in septic patients.LBP increases the sensitization of receptors of cells of the immune system: macrophages, monocytes, neutrophils to bacterial lipopolysaccharide, which leads to the activation of the immune response by releasing pro-inflammatory mediators. LBP appears to be an effective biomarker for bacterial translocation and the development of septic complications.I-FABP is a protein that is located on the villi of mature enterocytes. An increase in the level of I-FABP in the blood serum is associated with a violation of the permeability of the intestinal wall, which has been proven in a number of studies.Paneth cells secrete the antimicrobial protein REG3α into the intestine, and in case of the intestinal wall damage, it moves into the bloodstream. This protein is a reliable biomarker of intestinal wall damage and bacterial translocation.Zonulin first described like it is a protein that playing a significant role in intestinal wall permeability. It opens the intracellular tight junctions between the cells of the duodenum and small intestine, which leads to an increase in the permeability of the intestinal wall. Therefore, serum zonulin is a marker of dysfunction and increased permeability of the intestinal barrier.3. Research methods The type of....
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
ClinicalTrials.gov - (2024) vom: 19. Apr. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
610 |
|---|
| Anmerkungen: |
Source: Link to the current ClinicalTrials.gov record., First posted: January 24, 2024, Last downloaded: ClinicalTrials.gov processed this data on April 24, 2024, Last updated: April 24, 2024 |
|---|
| fisyears: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
CTG009570586 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | CTG009570586 | ||
| 003 | DE-627 | ||
| 005 | 20240424010409.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240131s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)CTG009570586 | ||
| 035 | |a (UBBS_Klinische_Studien)NCT06221293 | ||
| 035 | |a (UBBS_Klinische_Studien)ИРН АР 19677271 | ||
| 035 | |a (UBBS_Klinische_Studien)ИРН AP19677271 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Correlation Between Intra-abdominal Pressure, Biomarkers of Bacterial Translocation and Intestinal Wall Damage |b Study of the Relationship Between Intra-abdominal Pressure, Biomarkers of Bacterial Translocation and Intestinal Wall Damage in Multiple Organ Dysfunction Syndrome. |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: Link to the current ClinicalTrials.gov record., First posted: January 24, 2024, Last downloaded: ClinicalTrials.gov processed this data on April 24, 2024, Last updated: April 24, 2024 | ||
| 520 | |a The aim of the project is to evaluate the impact of intra-abdominal hypertension, biomarkers of bacterial translocation and biomarkers of intestinal wall damage on the course and outcomes of the disease in patients with multiple organ dysfunction.Today the intestinal microflora translocation is considered as one of the key mechanism of an enhanced systemic inflammatory response that leads to multiple organ dysfunction. In the intensive care unit, in patients in serious condition changes in various body systems develop, including the immune system reacts with the production of endogenous pro-inflammatory mediators, and due to microcirculation disorders, ischemia and hypoxia of the intestinal wall, aggravated by an increase in intra-abdominal pressure, its permeability increases, its barrier function is impaired. As a result, bacteria and/or their endotoxins penetrate the damaged intestinal barrier and further enhance the immune response, which becomes systemic and ultimately leads to multiple organ dysfunction. When the described processes occur, the assessment of splanchnic blood flow becomes especially relevant.sCD14-ST (presepsin) and LBP (lipopolysaccharide-binding protein) are being studied as biomarkers of bacterial translocation, and I-FABP (Intestinal fatty-acid binding protein), REG3α (regenerating islet-derived protein-3α) and Zonulin (zonulin) are being studied as biomarkers of intestinal wall injury.The interaction of the macrophage membrane protein CD14 with peptidoglycans of gram-positive and lipopolysaccharides of the walls of gram-negative bacteria leads to the production of sCD14-ST. Presepsin is a biomarker for the early phase of sepsis and a predictor of outcome in septic patients.LBP increases the sensitization of receptors of cells of the immune system: macrophages, monocytes, neutrophils to bacterial lipopolysaccharide, which leads to the activation of the immune response by releasing pro-inflammatory mediators. LBP appears to be an effective biomarker for bacterial translocation and the development of septic complications.I-FABP is a protein that is located on the villi of mature enterocytes. An increase in the level of I-FABP in the blood serum is associated with a violation of the permeability of the intestinal wall, which has been proven in a number of studies.Paneth cells secrete the antimicrobial protein REG3α into the intestine, and in case of the intestinal wall damage, it moves into the bloodstream. This protein is a reliable biomarker of intestinal wall damage.Zonulin is a protein that playing a significant role in intestinal wall permeability. It opens the intracellular tight junctions between the cells of the duodenum and small intestine, which leads to an increase in the permeability of the intestinal wall. Therefore, serum zonulin is a marker of dysfunction and increased permeability of the intestinal barrier.In the databases of publications (Scopus, Web of Science) there were no articles on the study of the relationship between the level of biomarkers of intestinal translocation, the level of biomarkers of the intestinal wall damage and the level of intra-abdominal pressure in patients with multiple organ dysfunction syndrome. This study will allow a more in-depth study of the pathogenesis of intestinal microflora translocation in patients with multiple organ dysfunction syndrome, and will also allow using the results obtained to predict the course of this condition.Detection of blood serum biomarkers sCD14-ST, LBP, I-FABP, REG3α and Zonulin will be performed by enzyme immunoassay. The level of intra-abdominal pressure will be measured by the method of tonometry in the bladder through a urethral catheter using a portable invasive low pressure meter (IIND - 500/75) by Triton-Electronics LLC.The expected scientific results of studying the relationship between intra-abdominal pressure, the phenomenon of translocation of intestinal microflora into the systemic circulation with the pathogenesis and dynamics of the development of multiple organ dysfunction syndrome will have an impact on the further improvement of the treatment tactics of this pathology. Innovative methods for diagnosing the phenomenon of intestinal microflora translocation will have a positive effect on the development of laboratory diagnostics and science in Kazakhstan.Revealing of relationships between intestinal microflora translocation biomarkers, biomarkers of the intestinal wall damage and changes in intra-abdominal pressure will allow a more in-depth study of the pathogenetic mechanisms in the development and course of the multiple organ dysfunction syndrome, depending on its genesis, which will allow using the results obtained to predict the outcomes of this syndrome.2.2. The aim of the project is to evaluate the impact of intra-abdominal hypertension, biomarkers of bacterial translocation, and biomarkers of the intestinal wall damage on the course and outcomes of the disease in patients with multiple organ dysfunction.2.3. Project objectives:To evaluate the indicators of biomarkers of translocation of the intestinal microflora and biomarkers of the intestinal wall damage in the systemic circulation during the development and course of the syndrome of multiple organ dysfunction. Based on the obtained critical levels of markers of translocation of the intestinal microflora and markers of the intestinal wall damage, it will be possible to predict adverse outcomes in patients with multiple organ dysfunction syndrome.To identify differences in the level of markers of bacterial translocation of the intestinal microflora and the level of markers of the intestinal wall damage in patients with intra-abdominal hypertension. In patients with multiple organ dysfunction syndrome, the levels of biomarkers of bacterial translocation of the intestinal microflora and biomarkers of intestinal wall damage in the blood serum correlate with intra-abdominal pressure indicators, regardless of the etiology of intra-abdominal hypertension.Assess the impact of the level of intra-abdominal pressure on the development and course of the syndrome of multiple organ dysfunction. To assess the course of the syndrome of multiple organ dysfunction, an additional prognostic marker is the determination of the critical level of intra-abdominal pressure.Determine the critical levels of biomarkers of intestinal microflora translocation and biomarkers of intestinal wall damage to predict the outcome of diseases accompanied by the development of multiple organ dysfunction syndrome. The obtained critical levels of biomarkers of translocation of the intestinal microflora and biomarkers of the intestinal wall damage will be significant indicators in the syndrome of multiple organ dysfunction for predicting an unfavorable outcome.3. Scientific novelty and significance of the project Multiple Organ Dysfunction Syndrome (MODS) is a potentially reversible physiological disorder involving two or more organ systems not involved in the process resulting in intensive care unit (ICU) hospitalization. MODS results in longer ICU stays and, in severe cases, leads to high mortality (27%-100%).In this scientific project, it is planned to study the levels of biomarkers of bacterial translocation (sCD14-ST, LBP) levels of biomarkers of intestinal wall damage (I-FABP, REG3α and Zonulin) and intra-abdominal pressure in patients with multiple organ dysfunction syndrome.The interaction of the macrophage membrane protein CD14 with peptidoglycans of gram-positive and lipopolysaccharides of the walls of gram-negative bacteria leads to the production of sCD14-ST . Presepsin is a biomarker for the early phase of sepsis and a predictor of outcome in septic patients.LBP increases the sensitization of receptors of cells of the immune system: macrophages, monocytes, neutrophils to bacterial lipopolysaccharide, which leads to the activation of the immune response by releasing pro-inflammatory mediators. LBP appears to be an effective biomarker for bacterial translocation and the development of septic complications.I-FABP is a protein that is located on the villi of mature enterocytes. An increase in the level of I-FABP in the blood serum is associated with a violation of the permeability of the intestinal wall, which has been proven in a number of studies.Paneth cells secrete the antimicrobial protein REG3α into the intestine, and in case of the intestinal wall damage, it moves into the bloodstream. This protein is a reliable biomarker of intestinal wall damage and bacterial translocation.Zonulin first described like it is a protein that playing a significant role in intestinal wall permeability. It opens the intracellular tight junctions between the cells of the duodenum and small intestine, which leads to an increase in the permeability of the intestinal wall. Therefore, serum zonulin is a marker of dysfunction and increased permeability of the intestinal barrier.3. Research methods The type of... | ||
| 650 | 2 | |a Intra-Abdominal Hypertension | |
| 650 | 2 | |a Hypertension | |
| 650 | 2 | |a Syndrome | |
| 650 | 4 | |a Study Type: Observational | |
| 650 | 4 | |a Recruitment Status: Active, not recruiting | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t ClinicalTrials.gov |g (2024) vom: 19. Apr. |
| 773 | 1 | 8 | |g year:2024 |g day:19 |g month:04 |
| 856 | 4 | 0 | |u https://clinicaltrials.gov/show/NCT06221293 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 19 |c 04 | ||